What’s new with biomarker-driven clinical strategy in sepsis and circulatory failure?

被引：0
|
作者：
Armand Mekontso Dessap
Lorraine B. Ware
Lila Bouadma
机构：
[1] Hôpitaux Universitaires Henri Mondor,Assistance Publique
[2] Université Paris Est Créteil,Hôpitaux de Paris, DHU A
[3] Vanderbilt University School of Medicine,TVB, Service de Réanimation Médicale
[4] Hôpitaux Universitaires Paris Nord-Val de Seine,Faculté de Médecine de Créteil, IMRB, Groupe de Recherche Clinique CARMAS
[5] Paris,Division of Allergy, Pulmonary, and Critical Care Medicine, T1218 Medical Center North Department of Medicine
[6] INSERM,Assistance Publique
[7] IAME Team 5 DeScID : Decision Science in Infectious Diseases,Hôpitaux de Paris, Réanimation Médicale et des Maladies Infectieuses, Hôpital Bichat
[8] Control and Care,Claude
[9] UMR 1137,Bernard
[10] Sorbonne Paris Cité,University Paris Diderot
来源：
Intensive Care Medicine | 2016年 / 42卷
关键词：
Intensive Care Unit Patient; Circulatory Failure; Lactate Clearance; Central Venous Oxygen Saturation; Pancreatic Stone Protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：418 / 421
页数：3
相关论文
共 50 条
  • [21] Classification of Companion Diagnostics: A New Framework for Biomarker-Driven Patient Selection
    Huber, Cynthia
    Friede, Tim
    Stingl, Julia
    Benda, Norbert
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2022, 56 (02) : 244 - 254
  • [22] Biomarker-driven basket trial designs: origins and new methodological developments
    Tu, Yue
    Renfro, Lindsay A.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024,
  • [23] Biomarker-Driven Therapeutic Management of Alzheimer's Disease: Establishing the Foundations
    Cummings, J.
    Zhong, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (01) : 67 - 77
  • [24] Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas
    Koch, Raphael
    Christie, Amanda L.
    Crombie, Jennifer L.
    Palmer, Adam C.
    Plana, Deborah
    Shigemori, Kay
    Morrow, Sara N.
    Van Scoyk, Alexandria
    Wu, Wenchao
    Brem, Elizabeth A.
    Secrist, J. Paul
    Drew, Lisa
    Schuller, Alwin G.
    Cidado, Justin
    Letai, Anthony
    Weinstock, David M.
    BLOOD, 2019, 133 (06) : 566 - 575
  • [25] Biomarker-Driven Early Clinical Trials in Oncology A Paradigm Shift in Drug Development
    Tan, Daniel S. W.
    Thomas, George V.
    Garrett, Michelle D.
    Banerji, Udai
    de Bono, Johann S.
    Kaye, Stan B.
    Workman, Paul
    CANCER JOURNAL, 2009, 15 (05): : 406 - 420
  • [26] Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network
    Azuaje, Francisco
    Devaux, Yvan
    Wagner, Daniel R.
    BMC SYSTEMS BIOLOGY, 2010, 4
  • [27] Biomarker-driven prognostic model for risk prediction in heart failure: ready for Prime time?
    Wussler, Desiree
    Mueller, Christian
    EUROPEAN HEART JOURNAL, 2021, 42 (43) : 4465 - 4467
  • [28] Biomarker-Driven Phenotyping in Parkinson's Disease: A Translational Missing Link in Disease-Modifying Clinical Trials
    Espay, Alberto J.
    Schwarzschild, Michael A.
    Tanner, Caroline M.
    Fernandez, Hubert H.
    Simon, David K.
    Leverenz, James B.
    Merola, Aristide
    Chen-Plotkin, Alice
    Brundin, Patrik
    Kauffman, Marcelo A.
    Erro, Roberto
    Kieburtz, Karl
    Woo, Daniel
    Macklin, Eric A.
    Standaert, David G.
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2017, 32 (03) : 319 - 324
  • [29] Biomarker-driven indication selection in JTX-2011 ICONIC clinical trial.
    Hirsch, Heather Anne
    Reeves, Jason
    Zi, Tong
    Deshpande, Amit
    Yang, Guang
    Needham, Alexander
    Shu, Jenny
    Khattri, Arun
    Brisson, Ryan J.
    Tan, Carol
    Harvey, Christopher
    Law, Deborah
    Michaelson, Jennifer
    Trehu, Elizabeth G.
    Sathyanarayanan, Srirarn
    Seiwert, Tanguy Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Biomarker-Driven Developments in the Context of the New Regulatory Framework for Companion Diagnostics in the European Union
    Verbaanderd, Ciska
    Trullas Jimeno, Ana
    Engelbergs, Joerg
    Zander, Hilke
    Reischl, Ilona
    Moreno Oliver, Ana
    Vamvakas, Spiros
    Vleminckx, Camille
    Bouygues, Christelle
    Girard, Thomas
    Day, Francesca
    Frias, Zaide
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (02) : 316 - 324
12345